Back to search
Psoriatic Arthritis (PsA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Psoriatic Arthritis (PsA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Psoriatic Arthritis (PsA) trials you may qualify forThe purpose of this study is to evaluate the safety and how well guselkumab treatment works (efficacy) in participants with psoriatic arthritis (PsA; a chronic,…
This is a multi-center, double-blind, placebo-controlled, Phase 2, proof-of-concept basket study with the goal of assessing the efficacy and safety of SPY072 co…
The purpose of this study is to assess how well guselkumab works in improving symptoms of psoriatic arthritis (an inflammatory disease that affects the joints i…
This is a trial to find out how weight loss (achieved by the use of tirzepatide) or ixekizumab treatment affects the characteristics of skin, joint and fat tiss…
Primary purpose of the study is to assess the concentration of bimekizumab in mature human breast milk.
The purpose of this study is to assess the impact of adding two questions and pictures to the validated PEST on the potential diagnosis of PsA in participants w…
This is a study to assess the long-term safety, long-term efficacy and tolerability of bimekizumab administered subcutaneously (sc) in adult subjects with psori…
The purpose of this study is to evaluate the efficacy and safety of deucravacitinib versus placebo in participants with active psoriatic arthritis who are naïve…